Avid Bioservices to Report Financial Results for Third
TUSTIN, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics
Globe Newswire7-03-2023, 04:09
[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US 14-04-2025, 21:00